BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12125983)

  • 21. Prolonged Sox4 expression in oligodendrocytes interferes with normal myelination in the central nervous system.
    Potzner MR; Griffel C; Lütjen-Drecoll E; Bösl MR; Wegner M; Sock E
    Mol Cell Biol; 2007 Aug; 27(15):5316-26. PubMed ID: 17515609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of PinX1 in medulloblastomas.
    Chang Q; Pang JC; Li J; Hu L; Kong X; Ng HK
    Int J Cancer; 2004 Mar; 109(2):309-14. PubMed ID: 14750185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
    Schüller U; Koch A; Hartmann W; Garrè ML; Goodyer CG; Cama A; Sörensen N; Wiestler OD; Pietsch T
    Int J Cancer; 2005 Oct; 117(1):82-9. PubMed ID: 15880586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged glial expression of Sox4 in the CNS leads to architectural cerebellar defects and ataxia.
    Hoser M; Baader SL; Bösl MR; Ihmer A; Wegner M; Sock E
    J Neurosci; 2007 May; 27(20):5495-505. PubMed ID: 17507571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns and potential roles of SIRT1 in human medulloblastoma cells in vivo and in vitro.
    Ma JX; Li H; Chen XM; Yang XH; Wang Q; Wu ML; Kong QY; Li ZX; Liu J
    Neuropathology; 2013 Feb; 33(1):7-16. PubMed ID: 22537175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A molecular fingerprint for medulloblastoma.
    Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
    Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial medulloblastoma: case report of one family and review of the literature.
    von Koch CS; Gulati M; Aldape K; Berger MS
    Neurosurgery; 2002 Jul; 51(1):227-33; discussion 233. PubMed ID: 12182422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas.
    Lescop S; Lellouch-Tubiana A; Vassal G; Besnard-Guerin C
    J Neurooncol; 1999 Sep; 44(2):119-27. PubMed ID: 10619495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of central nervous system embryonal tumour outcome based on gene expression.
    Pomeroy SL; Tamayo P; Gaasenbeek M; Sturla LM; Angelo M; McLaughlin ME; Kim JY; Goumnerova LC; Black PM; Lau C; Allen JC; Zagzag D; Olson JM; Curran T; Wetmore C; Biegel JA; Poggio T; Mukherjee S; Rifkin R; Califano A; Stolovitzky G; Louis DN; Mesirov JP; Lander ES; Golub TR
    Nature; 2002 Jan; 415(6870):436-42. PubMed ID: 11807556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sox12 deletion in the mouse reveals nonreciprocal redundancy with the related Sox4 and Sox11 transcription factors.
    Hoser M; Potzner MR; Koch JM; Bösl MR; Wegner M; Sock E
    Mol Cell Biol; 2008 Aug; 28(15):4675-87. PubMed ID: 18505825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal and oncogenic roles for microRNAs in the developing brain.
    Fernandez-L A; Northcott PA; Taylor MD; Kenney AM
    Cell Cycle; 2009 Dec; 8(24):4049-54. PubMed ID: 19901543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
    Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
    J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
    Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
    Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
    Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
    Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
    Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
    Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.
    Su X; Gopalakrishnan V; Stearns D; Aldape K; Lang FF; Fuller G; Snyder E; Eberhart CG; Majumder S
    Mol Cell Biol; 2006 Mar; 26(5):1666-78. PubMed ID: 16478988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.
    Schofield D; West DC; Anthony DC; Marshal R; Sklar J
    Am J Pathol; 1995 Feb; 146(2):472-80. PubMed ID: 7856756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subgroup-specific alternative splicing in medulloblastoma.
    Dubuc AM; Morrissy AS; Kloosterhof NK; Northcott PA; Yu EP; Shih D; Peacock J; Grajkowska W; van Meter T; Eberhart CG; Pfister S; Marra MA; Weiss WA; Scherer SW; Rutka JT; French PJ; Taylor MD
    Acta Neuropathol; 2012 Apr; 123(4):485-499. PubMed ID: 22358458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").
    Herpers MJ; Budka H
    Clin Neuropathol; 1985; 4(1):12-8. PubMed ID: 3978900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.